» Articles » PMID: 36434613

Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) Deficiency Causes Age-dependent Progression of Female Osteoporosis

Abstract

Background: Nuclear factor erythroid 2-related factor 2 (Nrf2) is a crucial transcription factor for cellular redox homeostasis. The association of Nrf2 with elderly female osteoporotic has yet to be fully described. The aim was to elucidate a potential age-dependent Nrf2 contribution to female osteoporosis in mice.

Methods: Eighteen female wild type (WT) and 16 Nrf2-knockout (KO) mice were sacrificed at different ages (12 weeks = young mature adult and 90 weeks = old) to analyze their femurs. The morphological properties (trabecular and cortical) were evaluated by micro-computed tomography (μCT) and compared to gold standard histochemistry analysis. The quasi-static compression tests were performed to calculate the mechanical properties of bones. Additionally, the population of bone resorbing cells and aromatase expression by osteocytes was immunohistochemically evaluated and empty osteocyte lacunae was counted in cortical bone.

Results: Old Nrf2-KO mice revealed a significantly reduced trabecular bone mineral density (BMD), cortical thickness, cortical area, and bone fraction compared to old WT mice, regardless of no significant difference in skeletally mature young adult mice between WT and KO. Specifically, while all old WT mice showed thin metaphyseal trabeculae, trabecular bone was completely absent in 60% of old KO mice. Additionally, old KO mice showed significantly more osteoclast-like cells and fewer aromatase-positive osteocytes than WT mice, whereas the occurrence of empty osteocyte lacunae did not differ between both groups. Nrf2-KO mice further showed an age-dependently reduced fracture resilience compared to age-matched WT mice.

Conclusion: Our results suggest that chronic Nrf2 loss can lead to age-dependent progression of female osteoporosis.

Citing Articles

Tricarboxylic Acid Cycle Regulation of Metabolic Program, Redox System, and Epigenetic Remodeling for Bone Health and Disease.

Lian W, Wu R, Lin Y, Chen Y, Jahr H, Wang F Antioxidants (Basel). 2024; 13(4).

PMID: 38671918 PMC: 11047415. DOI: 10.3390/antiox13040470.


Oxidative stress as a key modulator of cell fate decision in osteoarthritis and osteoporosis: a narrative review.

Riegger J, Schoppa A, Ruths L, Haffner-Luntzer M, Ignatius A Cell Mol Biol Lett. 2023; 28(1):76.

PMID: 37777764 PMC: 10541721. DOI: 10.1186/s11658-023-00489-y.


Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy.

Bao J, Yan Y, Zuo D, Zhuo Z, Sun T, Lin H Front Nutr. 2023; 10:1178573.

PMID: 37215218 PMC: 10196368. DOI: 10.3389/fnut.2023.1178573.


The Contribution of the Nrf2/ARE System to Mechanotransduction in Musculoskeletal and Periodontal Tissues.

Fragoulis A, Tohidnezhad M, Kubo Y, Wruck C, Craveiro R, Bock A Int J Mol Sci. 2023; 24(9).

PMID: 37175428 PMC: 10177782. DOI: 10.3390/ijms24097722.

References
1.
Huang X, Shu H, Ren C, Zhu J . SIRT3 improves bone regeneration and rescues diabetic fracture healing by regulating oxidative stress. Biochem Biophys Res Commun. 2022; 604:109-115. DOI: 10.1016/j.bbrc.2022.03.001. View

2.
Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y . Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life. 2007; 59(1):27-33. DOI: 10.1080/15216540601156188. View

3.
Hamann C, Rauner M, Hohna Y, Bernhardt R, Mettelsiefen J, Goettsch C . Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. J Bone Miner Res. 2012; 28(3):627-38. DOI: 10.1002/jbmr.1803. View

4.
Parkinson I, Badiei A, Fazzalari N . Variation in segmentation of bone from micro-CT imaging: implications for quantitative morphometric analysis. Australas Phys Eng Sci Med. 2008; 31(2):160-4. DOI: 10.1007/BF03178592. View

5.
Brommage R, Jeter-Jones S, Xiong W, Liu J . MicroCT analyses of mouse femoral neck architecture. Bone. 2019; 145:115040. DOI: 10.1016/j.bone.2019.115040. View